. 2019 Nov 11;11:95–100. doi: 10.1016/j.ijpddr.2019.10.005

Table 3.

Factors associated with the eradication of D. fragilis.

	P- value	OR [95%CI]
Women	0.834	1.04 [0.72; 1.46]
Age (years)^a
≤5	0.873	1.04 [0.65; 1.66]
6-14	0.230	0.79 [0.54; 1.16]
Treatment^a
Paromomiycin	<0.001	5.64 [2.51; 12.6]
Metronidazole	0.002	1.84 [1.10; 3.08]
Others	0.098	1.74 [0.90; 3.35]
Coinfection byBlastocystis hominis	0.155	1.30 [0.91; 1.86]
Time until post-treatment control test (days)^a
0–30	0.091	1.61 [0.93; 2.78]
31–60	0.639	1.11 [0.72; 1.68]

Basal category; Age: ≥15, Treatment: Non-treatment, Time until test: 61–90 days.